全文获取类型
收费全文 | 476篇 |
免费 | 6篇 |
国内免费 | 15篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 20篇 |
妇产科学 | 6篇 |
基础医学 | 128篇 |
口腔科学 | 3篇 |
临床医学 | 14篇 |
内科学 | 121篇 |
皮肤病学 | 4篇 |
神经病学 | 23篇 |
特种医学 | 5篇 |
外科学 | 32篇 |
综合类 | 18篇 |
预防医学 | 22篇 |
眼科学 | 4篇 |
药学 | 20篇 |
肿瘤学 | 72篇 |
出版年
2023年 | 4篇 |
2022年 | 12篇 |
2021年 | 18篇 |
2020年 | 12篇 |
2019年 | 13篇 |
2018年 | 21篇 |
2017年 | 9篇 |
2016年 | 16篇 |
2015年 | 24篇 |
2014年 | 27篇 |
2013年 | 43篇 |
2012年 | 18篇 |
2011年 | 28篇 |
2010年 | 15篇 |
2009年 | 22篇 |
2008年 | 31篇 |
2007年 | 20篇 |
2006年 | 25篇 |
2005年 | 23篇 |
2004年 | 19篇 |
2003年 | 10篇 |
2002年 | 10篇 |
2001年 | 8篇 |
2000年 | 8篇 |
1999年 | 5篇 |
1998年 | 9篇 |
1997年 | 3篇 |
1996年 | 6篇 |
1995年 | 9篇 |
1994年 | 7篇 |
1993年 | 6篇 |
1992年 | 6篇 |
1991年 | 1篇 |
1984年 | 1篇 |
1981年 | 2篇 |
1980年 | 1篇 |
1974年 | 1篇 |
1971年 | 3篇 |
1967年 | 1篇 |
排序方式: 共有497条查询结果,搜索用时 15 毫秒
1.
Summary In various primary brain tumours of neuroepithelial tissue recombinant DNA techniques were used to demonstrate changes of the epidermal growth factor receptor gene, which is homologous to the c-erbB oncogene. Twenty-one of 40 grade III/IV tumours, but only 1 of 16 grade I/II tumours were found to contain amplified and/or rearranged c-erbB sequences. This highly significant difference suggest that c-erbB amplification, rearrangement, or both, are important steps in malignant transformation in a subset of patients with neuroepithelial tumours. 相似文献
2.
Glucocerebrosidase is a lysosomal enzyme responsible for hydrolysis of glucosylceramide to ceramide and glucose. Mutations disrupting the function of this enzyme cause autosomal recessive Gaucher disease. This disease is very heterogeneous. The clinical heterogeneity is due to a large number of mutations within the gene encoding glucocerebrosidase. To date 36 mutations have been described in Gaucher disease. In this part we present the mutations and review the more common ones. We also review the glucocerebrosidase natural activator, designated saposin C and mutations in its gene, associated with Gaucher disease. © 1994 Wiley-Liss, Inc. 相似文献
3.
Mendel Tuchman 《Human mutation》1993,2(3):174-178
Deletions of variable size involving one or more exons, 29 different missense, nonsense, or frameshift mutations, and three polymorphisms have been found in patients with ornithine transcarbamylase (OTC) deficiency. Most of the deletions and mutations were found in patients with severe disease manifested clinically as acute neonatal hyperammonemia. A small number of mutations or somatic mosaicism for deletions were found in males with “late onset” disease and in heterozygous females who were symptomatic. Approximately 10–15% of all molecular alterations associated with OTC defi ciency are large deletions involving all or part of the OTC gene with or without contiguous genes on the short arm of the X chromosome. Approximately 10% of all point mutations involve the CpG dinucleotide of codon 141 with a CGA→CAA transition producing a deleterious Arg→Gln substitu tion in position 109 of the mature enzyme and causing the elimination of a TaqI recognition site. The majority of the remaining mutations in the OTC gene are unique to the affected family and are usually not found in unrelated patients. To date, two mutations have been described in the sequence of the “leader” peptide, 23 mutations have been found in the coding sequence of the “mature” enzyme, and four mutations have been discovered in splicing recognition sites. Approximately 20 single base polymorphisms have been postulated to exist by comparing two reported OTC gene sequences; six of these substitutions cause amino acid changes of which three have been confirmed in patients. Of the known point mutations, 27 are single base substitutions: 17 missense, 6 nonsense, 4 splice site, and the remaining 2 are single base deletions. © 1993 Wiley-Liss, Inc. 相似文献
4.
Molecular basis of phenylketonuria and related hyperphenylalaninemias: mutations and polymorphisms in the human phenylalanine hydroxylase gene. 总被引:10,自引:0,他引:10
Mutations in the human phenylalanine hydroxylase gene producing phenylketonuria or hyperphenylalaninemia have now been identified in many patients from various ethnic groups. These mutations all exhibit a high degree of association with specific restriction fragment-length polymorphism haplotypes at the PAH locus. About 50 of these mutations are single-base substitutions, including six nonsense mutations and eight splicing mutations, with the remainder being missense mutations. One splicing mutation results in a 3 amino acid in-frame insertion. Two or 3 large deletions, 2 single codon deletions, and 2 single base deletions have been found. Twelve of the missense mutations apparently result from the methylation and subsequent deamination of highly mutagenic CpG dinucleotides. Recurrent mutation has been observed at several of these sites, producing associations with different haplotypes in different populations. About half of all missense mutations have been examined by in vitro expression analysis, and a significant correlation has been observed between residual PAH activity and disease phenotype. Since continuing advances in molecular methodologies have dramatically accelerated the rate in which new mutations are being identified and characterized, this register of mutations will be updated periodically. 相似文献
5.
Joanne Young Barbara Leggett Corinne Gustafson Michael Ward Jeffrey Searle Lesley Thomas Ron Buttenshaw Georgia Chenevix-Trench 《Human mutation》1993,2(5):351-354
Genomic instability, as demonstrated by the presence of additional alleles at short tandemly repeated (STR) loci, has recently been observed in colorectal tumours from individuals with hereditary non-polyposis colorectal cancer (HNPCC), and in some sporadic tumours. These neoplasms have been called replication error positive (RER+). In this study, we confirm the presence of genomic instability in a proportion of unselected colorectal carcinomas but find no evidence of instability in adenomas. We further report replication errors in a tetranucleotide sequence, and in STRs within two tumour suppressor genes. 108 colorectal adenocarcinomas and 46 adenomas were analysed for the presence of variant bands at 4–15 microsatellite markers. Seven (6.5%) of carcinomas were RER+, four of which originated from the proximal colon. Analysis of the adenomas and of matched adenoma-carcinoma and carcinoma-metastatic samples from four patients suggests that the replication errors may occur during the development of carcinomas but are rare in adenomas. © 1993 Wiley-Liss, Inc. 相似文献
6.
Sacha Gnjatic Brigitte Bressac-De Paillerets Jean-Grard Guillet Jeannine Choppin 《European journal of immunology》1995,25(6):1638-1642
In many cancer cells, the p53 gene displays point mutations that result in stabilization and accumulation of the p53 protein. Therefore, p53 peptides could be presented to the immune system by tumor cells; thus, p53 might be a suitable target antigen for developing an immunotherapy against tumors using cytotoxic T lymphocytes (CTL). To map candidate CTL epitopes, we synthesized 150 peptides of 8–11 residues that contained putative anchor motifs required for binding to common HLA class I molecules. They were tested for their capacity to promote the assembly of purified and refolded HLA-A1, A2, B7 and B8 molecules. The following wild-type p53 peptides were found to be reactive with the HLA molecules tested: 196–205 and 226–234 bound moderately to HLA-A1; 25–35, 65–73, 129–137, 187–197, 263–272 and 264–272 bound strongly, and 187–195 and 256–264 moderately to HLA-A2; 26–35, 63–73, 189–197, 249–257 and 321–330 bound strongly to HLA-B7; and 135–143, 210–218 and 375–383 bound weakly to HLA-B8. We also analyzed the effects of p53 mutations occurring naturally in tumors on peptide/HLA assembly. We found substitutions that enhanced, diminished or had no effect on the peptide binding to HLA molecules. Polymorphism at position 72 mainly affected peptide/HLA-B7 binding, the proline allele P72 giving a less-reactive peptide (63–73) than the arginine allele R72. We have ranked potential p53 epitopes according to their reactivity for purified HLA molecules, allowing the selection of appropriate peptides and HLA molecules to attempt CTL induction in vitro. 相似文献
7.
8.
Screening for mutations in candidate genes for hypospadias 总被引:2,自引:0,他引:2
Nordenskjöld A Friedman E Tapper-Persson M Söderhäll C Leviav A Svensson J Anvret M 《Urological research》1999,27(1):49-55
Hypospadias, a condition with a frontally placed urethral orifice on the penis, is the most common malformation in males.
During fetal development several components are necessary for normal male genital development. Testosterone and dihydrotestosterone
act via the androgen receptor but a defective receptor function results in different degrees of genital malformations. Testosterone-5α-reductase
converts testosterone to dihydrotestosterone, which is crucial for normal differentiation, and a total lack of this enzyme
results, in syndromes with hypospadias. The Wilms' tumour 1 (WT1) gene is expressed in the fetal gonad and genital malformations
can occur due to WT1 gene mutations. These genes are therefore strong candidate genes for hypospadias. We have analysed 35
boys with hypopadias and one girl diagnosed as with complete androgen insensitivity syndrome, using exon by exon polymerace
chain reaction (PCR) amplification of the AR, WT1 and 5α-reductase genes and screened for point mutations and performed subsequent
DNA sequencing. No mutations in any of these genes were found in the 26 patients with isolated hypospadias. Two patients with
severe hypospadias with cryptorchidism were found to carry mutations in the androgen receptor gene. Also the girl with clinically
diagnosed complete androgen insensitivity was found to be homozygous for a splice mutation in the 5α-reductase gene. In summary,
mutations in the WT1, AR and 5α-reductase genes are not common causes of isolated hypospadias.
Received: 1 October 1997 / Accepted: 4 May 1998 相似文献
9.
10.